Contact
searchSearch
HMP Global

Advertisement

ADVERTISEMENT

Videos

Ryan Ungaro, MD
Video
Ryan Ungaro, MD, on Everything You and Your Patients Need to Know: COVID-19 Vaccinations and IBD
05/23/2022
Patients with inflammatory bowel disease typically mount adequate humoral response to mRNA vaccines for COVID-19 with little to no risk of disease flare or adverse events, Dr Ungaro said at DDW 2022.
Patients with inflammatory bowel disease typically mount adequate humoral response to mRNA vaccines for COVID-19 with little to no risk of disease flare or adverse events, Dr Ungaro said at DDW 2022.
Patients with inflammatory bowel...
05/23/2022
Advances in Inflammatory Bowel Disease Network
Maia Kayal, MD
Conference Coverage
Maia Kayal, MD, on Managing Complex, Refractory UC
05/23/2022
Dr Kayal reviews the case-based discussion from DDW 2022 on how to manage a patient with complex ulcerative colitis.
Dr Kayal reviews the case-based discussion from DDW 2022 on how to manage a patient with complex ulcerative colitis.
Dr Kayal reviews the case-based...
05/23/2022
Advances in Inflammatory Bowel Disease Network
Tiffany Taft, PsyD
Conference Coverage
Tiffany Taft, PsyD, on PTSD Among Patients With IBD
05/23/2022
Dr Taft reviews her presentation from DDW 2022 on symptoms of post-traumatic stress disorder among patients with inflammatory bowel disease.
Dr Taft reviews her presentation from DDW 2022 on symptoms of post-traumatic stress disorder among patients with inflammatory bowel disease.
Dr Taft reviews her presentation...
05/23/2022
Advances in Inflammatory Bowel Disease Network

Advertisement

Ryan Ungaro, MD
Conference Coverage
Ryan Ungaro, MD, on Outcomes Among Patients With UC, MS, With Treatment-Emergent COVID-19
05/22/2022
Dr Ungaro discusses his poster presentation at Digestive Disease Week 2022 on treatment-emergent cases of COVID-19 among patients with ulcerative colitis and multiple sclerosis participating in phase 3 clinical trials of ozanimod, and how...
Dr Ungaro discusses his poster presentation at Digestive Disease Week 2022 on treatment-emergent cases of COVID-19 among patients with ulcerative colitis and multiple sclerosis participating in phase 3 clinical trials of ozanimod, and how...
Dr Ungaro discusses his poster...
05/22/2022
Advances in Inflammatory Bowel Disease Network
Gil Y. Melmed, MD
Videos
Gil Y. Melmed, MD, on What’s New in Treat-to-Target
04/30/2022
Gil Y. Melmed, MD, from Cedars-Sinai in Los Angeles, reviews his talk on what’s new in treat-to-target strategies for IBD, presented at the the April 30 virtual regional meeting of Advances in Inflammatory Bowel Disease.
Gil Y. Melmed, MD, from Cedars-Sinai in Los Angeles, reviews his talk on what’s new in treat-to-target strategies for IBD, presented at the the April 30 virtual regional meeting of Advances in Inflammatory Bowel Disease.
Gil Y. Melmed, MD, from...
04/30/2022
Advances in Inflammatory Bowel Disease Network
Gaurav Syal, MD
Videos
Gaurav Syal, MD, on Managing Severe Ulcerative Colitis
04/30/2022
Dr Syal goes over his talk at the April 30 virtual AIBD Regionals meeting on the management of patients with severe ulcerative colitis.
Dr Syal goes over his talk at the April 30 virtual AIBD Regionals meeting on the management of patients with severe ulcerative colitis.
Dr Syal goes over his talk at...
04/30/2022
Advances in Inflammatory Bowel Disease Network

Advertisement

Sara Horst
Videos
Sara Horst, MD, on When to Optimize and When to Switch Therapies in IBD
04/30/2022
In this video, Dr Horst gives a recap on her presentation at the AIBD Regional 2022 Virtual Meeting on April 30 on when to optimize treatment and when to switch therapies when managing patients with inflammatory bowel disease.
In this video, Dr Horst gives a recap on her presentation at the AIBD Regional 2022 Virtual Meeting on April 30 on when to optimize treatment and when to switch therapies when managing patients with inflammatory bowel disease.
In this video, Dr Horst gives a...
04/30/2022
Advances in Inflammatory Bowel Disease Network
Gil Y. Melmed, MD
Videos
Gil Y. Melmed, MD, on First-Line Treatment Pathways for IBD
04/30/2022
Gil Y. Melmed, MD, from Cedars-Sinai in Los Angeles, recaps his presentation on the therapeutic options for first-line therapy for IBD at the April 30 virtual regional meeting of Advances in Inflammatory Bowel Disease.
Gil Y. Melmed, MD, from Cedars-Sinai in Los Angeles, recaps his presentation on the therapeutic options for first-line therapy for IBD at the April 30 virtual regional meeting of Advances in Inflammatory Bowel Disease.
Gil Y. Melmed, MD, from...
04/30/2022
Advances in Inflammatory Bowel Disease Network
Gaurav Syal, MD
Videos
Gaurav Syal, MD, on What's New in Biosimilars?
04/28/2022
Dr Syal reviews his presentation at the virtual AIBD Regionals meeting on April 30 about new and upcoming information on biosimilars for inflammatory bowel disease.
Dr Syal reviews his presentation at the virtual AIBD Regionals meeting on April 30 about new and upcoming information on biosimilars for inflammatory bowel disease.
Dr Syal reviews his presentation...
04/28/2022
Advances in Inflammatory Bowel Disease Network

Advertisement

Gil Y. Melmed, MD
Videos
Gil Y. Melmed, MD, Previews the April 30 AIBD Regional Meeting
04/27/2022
Gil Y. Melmed, MD, from Cedars-Sinai in Los Angeles, reviews the program and speakers for the virtual regional meeting of Advances in Inflammatory Bowel Disease on April 30.
Gil Y. Melmed, MD, from Cedars-Sinai in Los Angeles, reviews the program and speakers for the virtual regional meeting of Advances in Inflammatory Bowel Disease on April 30.
Gil Y. Melmed, MD, from...
04/27/2022
Advances in Inflammatory Bowel Disease Network

Advertisement

Advertisement

Advertisement

Latest News

News
Impact of Concomitant Medications on Advanced Therapies for Ulcerative Colitis
11/12/2024
Most concomitant medications do not affect the efficacy or safety of advanced therapies in ulcerative colitis clinical trials, according to a recent study.
Most concomitant medications do not affect the efficacy or safety of advanced therapies in ulcerative colitis clinical trials, according to a recent study.
Most concomitant medications do...
11/12/2024
Advances in Inflammatory Bowel Disease Network
News
Assessing Transmural Healing and Response in Patients with Crohn's Disease
11/11/2024
The the modified Clermont score was found to be an easy-to-use tool for assessing transmural healing and transmural response in CD patients.
The the modified Clermont score was found to be an easy-to-use tool for assessing transmural healing and transmural response in CD patients.
The the modified Clermont score...
11/11/2024
Advances in Inflammatory Bowel Disease Network
News
MRE or IUS for Crohn’s Disease Imaging?
11/06/2024
Investigators found patients typically preferred intestinal ultrasound for diagnosis and monitoring of Crohn’s disease, while magnetic resonance enterography may be better for diagnosing relapse.
Investigators found patients typically preferred intestinal ultrasound for diagnosis and monitoring of Crohn’s disease, while magnetic resonance enterography may be better for diagnosing relapse.
Investigators found patients...
11/06/2024
Advances in Inflammatory Bowel Disease Network
News
Lupus and IBD Share Microbiome Features
10/18/2024
Researchers identified distinct microbial signatures with significant overlaps between systemic lupus erythematosus and inflammatory bowel disease.
Researchers identified distinct microbial signatures with significant overlaps between systemic lupus erythematosus and inflammatory bowel disease.
Researchers identified distinct...
10/18/2024
Advances in Inflammatory Bowel Disease Network
News
Standard Dosing of Infliximab Effective for Steroid-Refractory ASUC
10/18/2024
While infliximab proved safe and effective for inducing remission in acute severe ulcerative colitis, higher doses and varied induction strategies showed no significant change in response.
While infliximab proved safe and effective for inducing remission in acute severe ulcerative colitis, higher doses and varied induction strategies showed no significant change in response.
While infliximab proved safe and...
10/18/2024
Advances in Inflammatory Bowel Disease Network
News
The Risks of Placebo in IBD Drug Trials
10/18/2024
Investigators recommend alternative trial designs to reduce potential harms to placebo-receiving patients with inflammatory bowel disease.
Investigators recommend alternative trial designs to reduce potential harms to placebo-receiving patients with inflammatory bowel disease.
Investigators recommend...
10/18/2024
Advances in Inflammatory Bowel Disease Network
News
Endoscopic Healing Index Shows Limited Utility for Identifying CD Remission
10/08/2024
Researchers at the University of Chicago recommend using the EHI with another modality to accurately identify inflammation among patients with Crohn’s disease.
Researchers at the University of Chicago recommend using the EHI with another modality to accurately identify inflammation among patients with Crohn’s disease.
Researchers at the University of...
10/08/2024
Advances in Inflammatory Bowel Disease Network
News
Scores Predict Corticosteroid Failure Risk in Patients With ASUC
10/03/2024
Risk of rescue scores that include several clinical, laboratory, and endoscopic variables may help improve outcomes in patients with acute severe ulcerative colitis.
Risk of rescue scores that include several clinical, laboratory, and endoscopic variables may help improve outcomes in patients with acute severe ulcerative colitis.
Risk of rescue scores that...
10/03/2024
Advances in Inflammatory Bowel Disease Network
News
Previous Stricturing Increases Risk of Anastomotic Stricture in Postoperative CD
10/01/2024
Early detection and treatment are the keys to reducing risk of progressive disease.
Early detection and treatment are the keys to reducing risk of progressive disease.
Early detection and treatment...
10/01/2024
Advances in Inflammatory Bowel Disease Network
News
Ustekinumab Shows Superior Persistence in CD Patients With Prior Biologic Use
09/30/2024
When used after a first-line agent, ustekinumab had significantly better persistence than other biologics.
When used after a first-line agent, ustekinumab had significantly better persistence than other biologics.
When used after a first-line...
09/30/2024
Advances in Inflammatory Bowel Disease Network

Advertisement

Advertisement

Advertisement

Latest Podcasts

Millie Long
Video
Millie Long, MD, on Comparative Effectiveness in Ulcerative Colitis
10/21/2024
Dr Long reviews her presentation from the AIBD regional meeting on using comparative effectiveness data to choose from among the growing number of therapies for treating ulcerative colitis.
Dr Long reviews her presentation from the AIBD regional meeting on using comparative effectiveness data to choose from among the growing number of therapies for treating ulcerative colitis.
Dr Long reviews her presentation...
10/21/2024
Advances in Inflammatory Bowel Disease Network
IBD Drive time logo
Podcast
IBD Drive Time: Drs James Lewis and Laura Raffals on SPARC
10/21/2024
Dr Raymond Cross hosts Drs James Lewis and Laura Raffals in a discussion of SPARC, a study of adults with inflammatory bowel disease in which patients are followed prospectively to collect data about to allow prediction of disease course and...
Dr Raymond Cross hosts Drs James Lewis and Laura Raffals in a discussion of SPARC, a study of adults with inflammatory bowel disease in which patients are followed prospectively to collect data about to allow prediction of disease course and...
Dr Raymond Cross hosts Drs James...
10/21/2024
Advances in Inflammatory Bowel Disease Network
Freddy Caldera
Podcast
Freddy Caldera, DO, on the RSV Vaccine for Patients With IBD
10/11/2024
Dr Caldera, from the University of Wisconsin School of Medicine, provides an overview of the risks of respiratory syncytial virus to older adults, including patients with IBD, and the importance of ensuring patients receive this vaccine along...
Dr Caldera, from the University of Wisconsin School of Medicine, provides an overview of the risks of respiratory syncytial virus to older adults, including patients with IBD, and the importance of ensuring patients receive this vaccine along...
Dr Caldera, from the University...
10/11/2024
Advances in Inflammatory Bowel Disease Network
IBD Drive time logo
Podcast
IBD Drive Time: Updates on the PIANO Study of IBD and Pregnancy
10/07/2024
IBD Drive Time Hosts Millie Long, MD, and Raymond Cross, MD, discuss new recommendations for managing inflammatory bowel disease among pregnant patients or those wanting to conceive, resulting from updates to the landmark PIANO study. 
IBD Drive Time Hosts Millie Long, MD, and Raymond Cross, MD, discuss new recommendations for managing inflammatory bowel disease among pregnant patients or those wanting to conceive, resulting from updates to the landmark PIANO study. 
IBD Drive Time Hosts Millie...
10/07/2024
Advances in Inflammatory Bowel Disease Network
IBD Drive time logo
Podcast
IBD Drive Time: David Hudesman, MD, on Work Productivity in IBD
09/19/2024
Dr David Hudesman of NYU-Langone Health joins IBD Drive Time host Dr Raymond Cross to talk about how inflammatory bowel disease affects work productivity and social activities.
Dr David Hudesman of NYU-Langone Health joins IBD Drive Time host Dr Raymond Cross to talk about how inflammatory bowel disease affects work productivity and social activities.
Dr David Hudesman of NYU-Langone...
09/19/2024
Advances in Inflammatory Bowel Disease Network
IBD Drive time logo
Podcast
IBD Drive Time: Erin Forster, MD, on Risankizumab for Ulcerative Colitis
09/03/2024
Dr Erin Forster of the Medical University of South Carolina joins IBD Drive Time hosts Dr Millie Long and Dr Raymond Cross to review results of the trials for risankizumab in ulcerative colitis and discuss its positioning in treatment.
Dr Erin Forster of the Medical University of South Carolina joins IBD Drive Time hosts Dr Millie Long and Dr Raymond Cross to review results of the trials for risankizumab in ulcerative colitis and discuss its positioning in treatment.
Dr Erin Forster of the Medical...
09/03/2024
Advances in Inflammatory Bowel Disease Network
IBD Drive time logo
Podcast
IBD Drive Time: Dr Jana Al Hashash on Diet and Nutrition in IBD Care
08/05/2024
Dr Jana Al Hashash from Mayo Clinic—Florida offers guidance on how diet can affect IBD and the best approaches to maintaining adequate nutrition, along with hosts Millie Long, MD, and Raymond Cross, MD.
Dr Jana Al Hashash from Mayo Clinic—Florida offers guidance on how diet can affect IBD and the best approaches to maintaining adequate nutrition, along with hosts Millie Long, MD, and Raymond Cross, MD.
Dr Jana Al Hashash from Mayo...
08/05/2024
Advances in Inflammatory Bowel Disease Network
Shubha Bhat
Podcast
Shubha Bhat, PharmD, on the Role of the Clinical Pharmacist in IBD
07/25/2024
Dr Bhat reports on the recent systematic review and RAND consensus process to define the role of the clinical pharmacist in caring for patients with inflammatory bowel disease.
Dr Bhat reports on the recent systematic review and RAND consensus process to define the role of the clinical pharmacist in caring for patients with inflammatory bowel disease.
Dr Bhat reports on the recent...
07/25/2024
Advances in Inflammatory Bowel Disease Network
IBD Drive time logo
Podcast
IBD Drive Time: The Best of DDW, Part 2
07/18/2024
In part 2 of this podcast, cohost Dr Millie Long discusses her picks for the "Best of DDW" on inflammatory bowel disease with her cohost, Dr Ray Cross.
In part 2 of this podcast, cohost Dr Millie Long discusses her picks for the "Best of DDW" on inflammatory bowel disease with her cohost, Dr Ray Cross.
In part 2 of this podcast,...
07/18/2024
Advances in Inflammatory Bowel Disease Network
IBD Drive time logo
Podcast
IBD Drive Time: Best of DDW, Part 1
07/09/2024
In the first episode of this two-part series, Dr Raymond Cross of Mercy Medical Center reviews his top picks for the best abstracts on inflammatory bowel disease presented at this year's Digestive Disease Week with cohost Dr Millie Long of...
In the first episode of this two-part series, Dr Raymond Cross of Mercy Medical Center reviews his top picks for the best abstracts on inflammatory bowel disease presented at this year's Digestive Disease Week with cohost Dr Millie Long of...
In the first episode of this...
07/09/2024
Advances in Inflammatory Bowel Disease Network

Advertisement

Advertisement

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use